Ahead of VIPOS 2025 – VS International Precision Oncology Summit, Chennai
Ovarian cancer, often referred to as the “silent killer,” is among the most challenging cancers in women, largely due to its subtle symptoms and late diagnosis. But in the era of precision medicine, hope is not only alive but growing stronger. At the heart of this evolution is a concept that goes far beyond one specialty or one doctor: the multidisciplinary approach.
As we look ahead to VIPOS 2025, where global leaders in cancer care will gather to explore the future of precision oncology, it is the ideal time to reflect on why collaborative care is not just helpful but essential in improving outcomes in ovarian cancer.
What Is a Multidisciplinary Approach?
In simple terms, it means bringing together experts from different specialties to design and deliver the best possible care for each patient. This may include:
- Gynecologic oncologists who specialize in ovarian cancer surgery
- Medical oncologists guiding chemotherapy or targeted therapies
- Radiation oncologists where appropriate
- Radiologists and pathologists for precise diagnosis and staging
- Genetic counselors to evaluate hereditary risks like BRCA mutations
- Palliative care specialists, fertility experts, nutritionists, and psychologists who support the patient beyond just the disease
Each member of this team brings a unique perspective, and when they work in harmony, treatment becomes smarter, faster, and more patient-centered.
Why It Matters
1. Early and Accurate Diagnosis:
Ovarian cancer is often diagnosed in the later stages. A multidisciplinary team ensures quicker access to imaging, tissue diagnosis, and genetic testing, leading to timely intervention.
2. Personalized Treatment Plans:
No two ovarian cancers are alike. Based on pathology, molecular profiling, and the patient’s overall health, treatment can range from surgery-first to neoadjuvant chemotherapy or targeted therapies. Having multiple specialists weigh in helps tailor the strategy.
3. Better Surgical Outcomes:
Debulking surgery (removing as much of the tumor as possible) is a cornerstone of ovarian cancer treatment. Studies show that high-volume centers with multidisciplinary teams achieve better surgical outcomes and survival rates.
4. Holistic Support:
Cancer is not just a physical disease. Emotional, nutritional, and financial challenges are real. Multidisciplinary teams ensure no part of the patient’s journey is ignored.
5. Access to Clinical Trials and Innovation:
Patients managed by coordinated teams are more likely to be considered for clinical trials and emerging treatments, including PARP inhibitors, immunotherapies, and maintenance strategies.
For the Patient, It Means One Thing: Empowerment
Imagine a woman newly diagnosed with ovarian cancer. Instead of navigating a maze of appointments alone, she walks into a tumor board meeting, or virtually attends one, where ten minds are focused solely on her case. She is not a statistic. She is the center of a coordinated effort, and every step of her care is planned with precision and compassion.
This is the promise of multidisciplinary care.
Looking Ahead: VIPOS 2025
At VIPOS 2025 in Chennai, this very topic will take center stage in an exclusive panel discussion on ovarian cancer, bringing together leading gynecologic oncologists, researchers, and precision medicine experts. Through case-based conversations and cross-specialty insights, the session will showcase how teamwork, technology, and empathy are reshaping ovarian cancer care.
Whether you’re a medical professional, a caregiver, or someone personally touched by cancer, understanding and advocating for a multidisciplinary approach can transform outcomes.
Because when we fight cancer together, from all angles, we fight smarter.
Join the conversation at VIPOS 2025, where precision meets collaboration, and every patient counts.